Subscribe To
Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine, announces the signing of a research collaboration agreement with Immgenuity, Inc. The joint research will focus on using Immgenuity’s IMTV014 and Biostax’s Lodonal™ and JKB-122 both independently and together to determine if […] The post Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV app...
Read More
Content Topics
Biostax
Corp
Signs
Collaboration
Agreement
With
Immgenuity
Immgenuity
Pursue
Remission
Forex
Posted: Aug 29 2023, 13:05
Author Name: forextv
Views: 092048